Identification of DNA repair-based biomarkers related to treatment outcome in head and neck cancers

被引：0
|
作者：
Muggiolu, G. [1 ]
Libert, S. [1 ]
Treillard, B. [1 ]
Alfonse, G. [2 ]
Philouze, P. [3 ]
Rodriguez-Lafrasse, C. [2 ]
Lauret, A. [4 ]
Ceruse, P. [3 ]
Righini, C. A. [5 ]
Sauvaigo, S. [1 ]
机构：
[1] LXRepair, Res & Dev, La Tronche, France
[2] Hosp Civils Lyon, Biochem & Mol Biol, Pierre Benite, France
[3] Hosp Civils Lyon, Head Neck, Lyon, France
[4] CNRS, UMR 5822, Cellular & Mol Radiobiol, Oullins, France
[5] Michallon Hosp, Head Neck Surg, Grenoble, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1929
引用
收藏
页码：S1643 / S1644
页数：2
相关论文
共 50 条
  • [31] Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
    Michiels, Stefan
    Danoy, Patrick
    Dessen, Philippe
    Bera, Alex
    Boulet, Thomas
    Bouchardy, Christine
    Lathrop, Mark
    Sarasin, Alain
    Benhamou, Simone
    CARCINOGENESIS, 2007, 28 (08) : 1731 - 1739
  • [32] Identification of molecular biomarkers for head and neck cancer progression
    Hasina, Rifat
    Sigari, Farhad
    Kuo, Winston
    Martin, Leslie
    Lingen, Mark
    CANCER RESEARCH, 2008, 68 (09)
  • [33] Predicting the outcome of head and neck cancers to radiotherapy with multivariate modelling
    Datta, NR
    Kumar, S
    Nagar, YS
    Pandey, CM
    Sharma, SK
    Ayyagari, S
    PROGRESS IN RADIO-ONCOLOGY VI, 1998, : 543 - 548
  • [34] Multimodal stratification of predictive biomarkers in head and neck cancers: A focus on cytokine-based immunotherapy
    Ramos, Corinne
    Ruez, Richard
    Delebecq, Sandra
    Senechal, Victor
    CANCER RESEARCH, 2024, 84 (06)
  • [35] WIDENING PERSPECTIVES - QUALITY-OF-LIFE AS A MEASURE OF OUTCOME IN THE TREATMENT OF PATIENTS WITH CANCERS OF THE HEAD AND NECK
    MORRIS, J
    ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1994, 30B (01): : 29 - 31
  • [36] Long-term Outcome of Interstitial Alpha Radionuclide Treatment for Skin and Head and Neck Cancers
    Popovtzer, Aron
    Mizrachi, Aviram
    D'Andrea, Mark A.
    VanderWalde, Noam A.
    Kurman, Noga
    Rosenfeld, Eli
    Ben-Hur, Ran
    Feliciani, Giacomo
    Bellia, Salvatore Roberto
    Silvern, David
    Sarnelli, Anna
    Ballo, Matthew T.
    Patra, Pradeep
    Cohen, Gil'ad N.
    Damato, Antonio L.
    Shkedy, Yotam
    Den, Robert B.
    Barker, Christopher A.
    Charas, Tomer
    Hirshoren, Nir
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1910 - S1911
  • [37] The epidemiology, treatment, and determinants of outcome of primary head and neck cancers at the Jos University Teaching Hospital
    Adoga, Adeyi A.
    Kokong, Daniel D.
    Ma'an, Nuhu D.
    Silas, Olugbenga A.
    Dauda, Ayuba M.
    Yaro, John P.
    Mugu, Joyce G.
    Mgbachi, Chukwunonso J.
    Yabak, Caleb J.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (03) : 183 - 187
  • [38] Circulating non-coding RNAs as biomarkers of head and neck cancers
    Khoury, S.
    Clark, J.
    Elliott, M.
    Tran, N.
    FEBS JOURNAL, 2013, 280 : 39 - 39
  • [39] Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
    Boguszewicz, Lukasz
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Critical biomarkers of epithelial-mesenchymal transition in the head and neck cancers
    Natarajan, Jayalakshmi
    Chandrashekar, Chetana
    Radhakrishnan, Raghu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (03) : 512 - 518
12345